R&D Unit

Our R&D Unit

Bio­log­ics R&D and Pro­duc­tion Unit

Anti­body and CAR‑T cell R&D ser­vices span dis­cov­ery to pre­clin­i­cal
opti­miza­tion, accel­er­at­ing immunother­a­py devel­op­ment.

Con­tact Us
rdunit

LxBio Ab, our anti­body research and dis­cov­ery divi­sion dif­fer­en­ti­ates itself through high-pre­ci­sion anti­body dis­cov­ery enabled by advanced Sin­gle B‑Cell Screen­ing tech­nolo­gies, inte­grat­ing deep sci­en­tif­ic exper­tise with proven oper­a­tional exe­cu­tion.

Sup­port­ed by a mul­ti­dis­ci­pli­nary team with exten­sive expe­ri­ence in immunol­o­gy and bio­log­ics devel­op­ment, the plat­form enables the rapid iden­ti­fi­ca­tion of rare, high-val­ue anti­body can­di­dates with supe­ri­or speci­fici­ty and func­tion­al­i­ty.

This pro­pri­etary anti­body dis­cov­ery capa­bil­i­ty sup­ports the advance­ment of Lxbio’s inter­nal ther­a­peu­tic pipeline while also pro­vid­ing tai­lored dis­cov­ery and research ser­vices to biotech­nol­o­gy and phar­ma­ceu­ti­cal part­ners.

Sup­port­ed by an expe­ri­enced sci­en­tif­ic team and state-of-the-heart plat­forms, Lxbio Ab dri­ves inter­nal bio­log­ics inno­va­tion while pro­vid­ing anti­body dis­cov­ery and research ser­vices to biotech­nol­o­gy and phar­ma­ceu­ti­cal part­ners. Dis­cov­er More

image1

End-to-End Expertise in Antibody Discovery

Lxbio offers inte­grat­ed solu­tions from dis­cov­ery to pro­duc­tion, spe­cial­iz­ing in anti­body devel­op­ment, engi­neer­ing, and cell line gen­er­a­tion. Our deep sci­en­tif­ic knowl­edge and cut­ting-edge tech­nolo­gies ensure faster time­lines and high­er suc­cess rates in your R&D projects.

Tailored, Client-Centric Approach

We under­stand that every project is unique. At Lxbio, we pride our­selves on flex­i­bil­i­ty and close col­lab­o­ra­tion, cus­tomiz­ing our ser­vices to meet your spe­cif­ic goals..

Quality, Speed, and Reliability

Our CRO ser­vices are built around rig­or­ous qual­i­ty stan­dards, trans­par­ent com­mu­ni­ca­tion, and effi­cient deliv­ery. With Lxbio, you gain a trust­ed part­ner com­mit­ted to deliv­er­ing results-on time and on tar­get.

Dis­cov­ery and Engi­neer­ing
  • Sin­gle B‑cell Tech­nol­o­gy
  • Phage Dis­play
  • TPP-focused Opti­miza­tion

Pro­duc­tion

  • Mam­malian and E. coli pro­duc­tions
  • Opti­mized expres­sion vec­tor

Char­ac­ter­i­za­tion

  • Func­tion­al and struc­tur­al
  • High-through­put
  • Tai­lored approach­es

Sta­ble cell lines

  • Sin­gle Cell tech­nol­o­gy allow­ing real-time selec­tion for qual­i­ty and pro­duc­tiv­i­ty
  • Decreased time­lines
Con­tact Us